Marstacimab prophylaxis in hemophilia AB without inhibitors results from the phase 3 BASIS trial

Simple item page
dc.article.end-page1663en
dc.article.start-page1654en
dc.citation.doi10.1182/BLOOD.2024027468en
dc.contributor.authorD Matinoen
dc.contributor.authorA Palladinoen
dc.contributor.authorC. T Tayloren
dc.contributor.authorE Hwangen
dc.contributor.authorJohnny Mahlanguen
dc.contributor.authorE et alen
dc.date.accessioned2026-04-12T17:05:34Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0006-4971en
dc.identifier.urihttps://hdl.handle.net/10539/48994
dc.journal.titleMarstacimab prophylaxis in hemophilia AB without inhibitors results from the phase 3 BASIS trialen
dc.journal.volume146en
dc.publisherAMER SOC HEMATOLOGYen
dc.titleMarstacimab prophylaxis in hemophilia AB without inhibitors results from the phase 3 BASIS trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
391.92 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)